The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
NCT01616862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53
Last updated 2015-06-02
Summary
Pseudomonas aeruginosa (Pa) is the bacterium that causes one of the most consequential lung infections in people with CF. Many young children do not have Pa in their lungs but will become infected as they get older. The investigators want to learn more about how Pa is passed from person to person, especially to someone with Cystic Fibrosis (CF).
Conditions
- Pseudomonas Aeruginosa
- Cystic Fibrosis
Sponsors & Collaborators
-
Zafer Soultan
lead OTHER
Principal Investigators
-
Zafer Soultan, MD · State University of New York - Upstate Medical University
Eligibility
- Min Age
- 5 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2013-06-30
- Completion
- 2013-08-31
Countries
- United States
Study Locations
More Related Trials
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis
NCT01694069 ·Status: TERMINATED ·Phase: PHASE4
-
Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center.
NCT03910920 ·Status: UNKNOWN
-
Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis
NCT00531531 ·Status: COMPLETED
-
Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations
NCT04341532 ·Status: COMPLETED
-
Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations
NCT00381628 ·Status: COMPLETED
-
Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients
NCT01229553 ·Status: WITHDRAWN ·Phase: NA
-
Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life
NCT00977158 ·Status: WITHDRAWN
-
Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa
NCT02248922 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis
NCT04335370 ·Status: COMPLETED
-
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
NCT07312734 ·Status: NOT_YET_RECRUITING
-
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
NCT00585364 ·Status: COMPLETED
-
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
NCT05686837 ·Status: ENROLLING_BY_INVITATION
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients
NCT02363764 ·Status: COMPLETED
-
A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis
NCT01667094 ·Status: UNKNOWN ·Phase: PHASE4
-
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 ·Status: COMPLETED
-
Microbial Community Composition and Metabolism in Cystic Fibrosis
NCT00954018 ·Status: COMPLETED
-
Cystic Fibrosis Blood Neutrophils
NCT04970225 ·Status: COMPLETED ·Phase: NA
-
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
NCT06413459 ·Status: RECRUITING
-
Airway Microbiome of Cystic Fibrosis Patients
NCT06057558 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Antimicrobial Resistance in Cystic Fibrosis (CF)
NCT00360503 ·Status: COMPLETED
-
COVID-19 Antibody Responses In Cystic Fibrosis
NCT05074680 ·Status: ACTIVE_NOT_RECRUITING
-
Near Patient Microbial Testing in Cystic Fibrosis
NCT01877707 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Antibody Responses in Cystic Fibrosis
NCT05561868 ·Status: ACTIVE_NOT_RECRUITING